Search

Your search keyword '"transferred cold atmospheric plasma"' showing total 3 results
Start Over Descriptor "transferred cold atmospheric plasma"
3 results on '"transferred cold atmospheric plasma"'

1. Transferred Cold Atmospheric Plasma Treatment on Melanoma Skin Cancer Cells with/without Catalase Enzyme In Vitro.

Author

Chen, Yun-Hsuan, Hsieh, Jang-Hsing, Wang, I-Te, Jheng, Pei-Ru, Yeh, Yi-Yen, Lee, Jyh-Wei, Bolouki, Nima, and Chuang, Er-Yuan

Subjects
LOW temperature plasmas, SKIN cancer, CANCER cells, REACTIVE nitrogen species, PRECANCEROUS conditions, CATALASE
Abstract

Cold atmospheric plasma (CAP) is a promising tool to overcome certain cancerous and precancerous conditions in dermatology. A scheme of transferred CAP was first developed to treat melanoma (B16F10) skin cancer cells as well as non-malignant (L929) cells in vitro. CAP was transferred using a silicone tube with a jet system that was developed and was assessed as to whether it could generate reactive oxygen and nitrogen species (RONS) at near-room temperature. The transferred CAP was characterized electrically and spectroscopically. Biological data showed that the transferred CAP killed cancer cells but not non-malignant (L929) cells. Plasma treatment was effective with a time duration of 30 s, whereas non-malignant (L929) cells were less damaged during plasma treatment. In addition, catalase (CAT) enzyme was applied to neutralize and detoxify the RONS generated by the transferred CAP. These findings suggest that transferred CAP can be considered a melanoma cancer therapy. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

2. Transferred Cold Atmospheric Plasma Treatment on Melanoma Skin Cancer Cells with/without Catalase Enzyme In Vitro

Author

Yun-Hsuan Chen, Jang-Hsing Hsieh, I-Te Wang, Pei-Ru Jheng, Yi-Yen Yeh, Jyh-Wei Lee, Nima Bolouki, and Er-Yuan Chuang

Subjects
melanoma cell (B16F10), plasma cancer therapy, cold atmospheric plasma (CAP), transferred cold atmospheric plasma, reactive oxygen species (ROS), reactive nitrogen species (RNS), Technology, Engineering (General). Civil engineering (General), TA1-2040, Biology (General), QH301-705.5, Physics, QC1-999, Chemistry, QD1-999
Abstract

Cold atmospheric plasma (CAP) is a promising tool to overcome certain cancerous and precancerous conditions in dermatology. A scheme of transferred CAP was first developed to treat melanoma (B16F10) skin cancer cells as well as non-malignant (L929) cells in vitro. CAP was transferred using a silicone tube with a jet system that was developed and was assessed as to whether it could generate reactive oxygen and nitrogen species (RONS) at near-room temperature. The transferred CAP was characterized electrically and spectroscopically. Biological data showed that the transferred CAP killed cancer cells but not non-malignant (L929) cells. Plasma treatment was effective with a time duration of 30 s, whereas non-malignant (L929) cells were less damaged during plasma treatment. In addition, catalase (CAT) enzyme was applied to neutralize and detoxify the RONS generated by the transferred CAP. These findings suggest that transferred CAP can be considered a melanoma cancer therapy.

Published
2021
Full Text
View/download PDF

3. Transferred Cold Atmospheric Plasma Treatment on Melanoma Skin Cancer Cells with/without Catalase Enzyme In Vitro

Author

Jang-Hsing Hsieh, Jyh Wei Lee, Yun-Hsuan Chen, Nima Bolouki, Yi-Yen Yeh, Er Yuan Chuang, I-Te Wang, and Jheng Pei-Ru

Subjects
Technology, QH301-705.5, QC1-999, cold atmospheric plasma (CAP), chemistry.chemical_element, Atmospheric-pressure plasma, reactive oxygen species (ROS), Oxygen, 03 medical and health sciences, 0302 clinical medicine, medicine, General Materials Science, Biology (General), Instrumentation, QD1-999, 030304 developmental biology, Fluid Flow and Transfer Processes, chemistry.chemical_classification, 0303 health sciences, biology, Process Chemistry and Technology, Melanoma, transferred cold atmospheric plasma, Physics, catalase, General Engineering, melanoma cell (B16F10), medicine.disease, Engineering (General). Civil engineering (General), Molecular biology, In vitro, Computer Science Applications, Chemistry, Enzyme, chemistry, plasma cancer therapy, Catalase, 030220 oncology & carcinogenesis, Cancer cell, biology.protein, reactive nitrogen species (RNS), Skin cancer, TA1-2040
Abstract

Cold atmospheric plasma (CAP) is a promising tool to overcome certain cancerous and precancerous conditions in dermatology. A scheme of transferred CAP was first developed to treat melanoma (B16F10) skin cancer cells as well as non-malignant (L929) cells in vitro. CAP was transferred using a silicone tube with a jet system that was developed and was assessed as to whether it could generate reactive oxygen and nitrogen species (RONS) at near-room temperature. The transferred CAP was characterized electrically and spectroscopically. Biological data showed that the transferred CAP killed cancer cells but not non-malignant (L929) cells. Plasma treatment was effective with a time duration of 30 s, whereas non-malignant (L929) cells were less damaged during plasma treatment. In addition, catalase (CAT) enzyme was applied to neutralize and detoxify the RONS generated by the transferred CAP. These findings suggest that transferred CAP can be considered a melanoma cancer therapy.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results